Countries in which studies (included in the synthesis) were conducted
USA (36); UK (England) (14); Canada (9); Netherlands (7); Sweden (7); Australia (6); Israel (5); Belgium (4); Finland (4); Norway (4); Ireland (3); New Zealand (3); Not reported (3); UK (Scotland) (3); Spain (2); Taiwan (2); Brazil (1); Denmark (1); Europe (1); France (1); Italy (1); Japan (1); South Africa (1)
Global/regional focus
Not yet available
Country focus
USA (36); UK (England) (14); Canada (9); Netherlands (7); Sweden (7); Australia (6); Israel (5); Belgium (4); Finland (4); Norway (4); Ireland (3); New Zealand (3); Not reported (3); UK (Scotland) (3); Spain (2); Taiwan (2); Brazil (1); Denmark (1); Europe (1); France (1); Italy (1); Japan (1); South Africa (1)
Low - and middle-income country (LMIC) focus
At least one included study was conducted in a low- or middle-income country
s
Additional details about the research
Type of document
Systematic review of effects
Type of question
Effectiveness
Focus
Specific
Target
Health system
Priority Area
Not applicable
Health system topic(s)
Delivery arrangements
By whom care is provided
Skill mix - Multidisciplinary teams
Staff - Training
Implementation strategies
Provider-targeted strategy
Educational material
Educational meeting
Theme
Optimal aging
Domain
Technologies
Drugs
Providers
Physician
Nurse
Pharmacist
Publication details
Citation
Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The feasibility and the effect of deprescribing in older adults on mortality and health: A systematic review. British Journal of Clinical Pharmacology. 2016.